CXCL5 and atherosclerosis: Serum levels of chemokine CXCL5 have also been associated with intima-media thickness of the common carotid artery, a marker of preclinical atherosclerosis, and CXCL5 levels are reduced by anti-inflammatory statin therapy [42].